APA (7th ed.) Citation

D, D., C, H., H, G., D, K., SH, W., J, H., . . . M, H. (2026). Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus. The British journal of dermatology, 194(1), 86. https://doi.org/10.1093/bjd/ljaf311

Chicago Style (17th ed.) Citation

D, Didona, et al. "Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Desmoglein 3 Peptide-coupled Tolerizing Nanoparticles in Pemphigus." The British Journal of Dermatology 194, no. 1 (2026): 86. https://doi.org/10.1093/bjd/ljaf311.

MLA (9th ed.) Citation

D, Didona, et al. "Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Desmoglein 3 Peptide-coupled Tolerizing Nanoparticles in Pemphigus." The British Journal of Dermatology, vol. 194, no. 1, 2026, p. 86, https://doi.org/10.1093/bjd/ljaf311.